Physician profile
Amber Macfarlane
NPI 1922666965
$691.92
in general payments reported to CMS, 2019-2025
8 companies · $517 in 2025
The $517 reported for 2025 was more than what 83% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.41 · 2021: $15.29 · 2023: $73.84 · 2024: $71.85 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $164.06 | 2024-2025 | |
| Hydrocision, INC. | $143.90 | 2025 | Tenjet |
| Pacira Pharmaceuticals Incorporated | $120.29 | 2025 | Zilretta |
| Depuy Synthes Sales INC. | $102.41 | 2023-2025 | Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $91.33 | 2023-2025 | Gel-One Cross-Linked Hyaluronate |
| Trice Medical, INC. | $40.23 | 2025 | |
| Pacira Therapeutics, INC. | $15.29 | 2021 | |
| Merck Sharp & Dohme LLC | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Macfarlane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.